Clinical and biological implications of MYC activation: A common difference between MGUS and newly diagnosed multiple myeloma

10.1038/leu.2011.53

Saved in:
Bibliographic Details
Main Authors: Chng, W.-J., Huang, G.F., Chung, T.H., Ng, S.B., Gonzalez-Paz, N., Troska-Price, T., Mulligan, G., Chesi, M., Bergsagel, P.L., Fonseca, R.
Other Authors: CANCER SCIENCE INSTITUTE OF SINGAPORE
Format: Article
Published: 2014
Subjects:
MYC
Online Access:http://scholarbank.nus.edu.sg/handle/10635/110728
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-110728
record_format dspace
spelling sg-nus-scholar.10635-1107282023-10-25T21:16:38Z Clinical and biological implications of MYC activation: A common difference between MGUS and newly diagnosed multiple myeloma Chng, W.-J. Huang, G.F. Chung, T.H. Ng, S.B. Gonzalez-Paz, N. Troska-Price, T. Mulligan, G. Chesi, M. Bergsagel, P.L. Fonseca, R. CANCER SCIENCE INSTITUTE OF SINGAPORE bortezomib hyperdiploid MGUS MYC myeloma 10.1038/leu.2011.53 Leukemia 25 6 1026-1035 LEUKE 2014-11-26T09:59:32Z 2014-11-26T09:59:32Z 2011-06 Article Chng, W.-J., Huang, G.F., Chung, T.H., Ng, S.B., Gonzalez-Paz, N., Troska-Price, T., Mulligan, G., Chesi, M., Bergsagel, P.L., Fonseca, R. (2011-06). Clinical and biological implications of MYC activation: A common difference between MGUS and newly diagnosed multiple myeloma. Leukemia 25 (6) : 1026-1035. ScholarBank@NUS Repository. https://doi.org/10.1038/leu.2011.53 08876924 http://scholarbank.nus.edu.sg/handle/10635/110728 000291386900017 Scopus
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
topic bortezomib
hyperdiploid
MGUS
MYC
myeloma
spellingShingle bortezomib
hyperdiploid
MGUS
MYC
myeloma
Chng, W.-J.
Huang, G.F.
Chung, T.H.
Ng, S.B.
Gonzalez-Paz, N.
Troska-Price, T.
Mulligan, G.
Chesi, M.
Bergsagel, P.L.
Fonseca, R.
Clinical and biological implications of MYC activation: A common difference between MGUS and newly diagnosed multiple myeloma
description 10.1038/leu.2011.53
author2 CANCER SCIENCE INSTITUTE OF SINGAPORE
author_facet CANCER SCIENCE INSTITUTE OF SINGAPORE
Chng, W.-J.
Huang, G.F.
Chung, T.H.
Ng, S.B.
Gonzalez-Paz, N.
Troska-Price, T.
Mulligan, G.
Chesi, M.
Bergsagel, P.L.
Fonseca, R.
format Article
author Chng, W.-J.
Huang, G.F.
Chung, T.H.
Ng, S.B.
Gonzalez-Paz, N.
Troska-Price, T.
Mulligan, G.
Chesi, M.
Bergsagel, P.L.
Fonseca, R.
author_sort Chng, W.-J.
title Clinical and biological implications of MYC activation: A common difference between MGUS and newly diagnosed multiple myeloma
title_short Clinical and biological implications of MYC activation: A common difference between MGUS and newly diagnosed multiple myeloma
title_full Clinical and biological implications of MYC activation: A common difference between MGUS and newly diagnosed multiple myeloma
title_fullStr Clinical and biological implications of MYC activation: A common difference between MGUS and newly diagnosed multiple myeloma
title_full_unstemmed Clinical and biological implications of MYC activation: A common difference between MGUS and newly diagnosed multiple myeloma
title_sort clinical and biological implications of myc activation: a common difference between mgus and newly diagnosed multiple myeloma
publishDate 2014
url http://scholarbank.nus.edu.sg/handle/10635/110728
_version_ 1781788911812476928